---
$id: https://graph.org.ai/products/commodity/51162622
$type: Product
source: UNSPSC
code: "51162622"
title: "Fedrilate"
class: "51162600"
classTitle: "Antitussives and associated cough remedies"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Fedrilate

**UNSPSC Code**: 51162622
**Class**: [Antitussives and associated cough remedies](Antitussives and associated cough remedies.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antitussive agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) NT86R8M7J5. European Medicines Agency schedules Fedrilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07525MIG. Fedrilate generally arises in the molecular formula C20H29NO4. The term FEDRILATE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 23, no. 10 1969, list 9.) FEDRILATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule fedrilate under HS 29349990 and SITC 51579. As of Q4 2014, FEDRILATE remains US FDA's Preferred Term for this commodity. Fedrilate bears US NLM identifiers UMLS ID C0771169 and NCI Concept Code C81597. SMILES: O1CCC(CC1)(C1CCCCC1)C(=O)OC(CCN1CCOCC1)C.

